Thrombelastography Detects the Anticoagulant Effect of Rivaroxaban in Patients With Stroke | Zendy

Ritvij Bowry | Zendy; Stuart Fraser | Zendy; Joancy Archeval-Lao | Zendy; Stephanie Parker | Zendy; Chunyan Cai | Zendy; Mohammad H Rahbar | Zendy; James C. Grotta | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Thrombelastography Detects the Anticoagulant Effect of Rivaroxaban in Patients With Stroke

Author(s) -

Ritvij Bowry,

Stuart Fraser,

Joancy Archeval-Lao,

Stephanie Parker,

Chunyan Cai,

Mohammad H Rahbar,

James C. Grotta

Publication year - 2014

Publication title -

stroke

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 3.397

H-Index - 319

eISSN - 1524-4628

pISSN - 0039-2499

DOI - 10.1161/strokeaha.113.004016

Subject(s) - thrombelastography , medicine , rivaroxaban , stroke (engine) , thrombolysis , atrial fibrillation , thromboelastography , anticoagulant , anesthesia , cardiology , coagulation , warfarin , myocardial infarction , engineering , mechanical engineering

Factor Xa inhibitors are prescribed for stroke prevention in atrial fibrillation. Managing such patients is challenging especially if they are eligible for thrombolysis because there is no rapidly available test to detect the effect of such medications. Thrombelastography analyzes the dynamics of coagulation and can be rapidly performed. We sought to determine whether thrombelastography can detect the anticoagulation effect of factor Xa inhibitors in patients with stroke.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research